全文获取类型
收费全文 | 17339篇 |
免费 | 1271篇 |
国内免费 | 511篇 |
专业分类
耳鼻咽喉 | 231篇 |
儿科学 | 238篇 |
妇产科学 | 201篇 |
基础医学 | 1157篇 |
口腔科学 | 467篇 |
临床医学 | 1596篇 |
内科学 | 1381篇 |
皮肤病学 | 144篇 |
神经病学 | 551篇 |
特种医学 | 1094篇 |
外国民族医学 | 4篇 |
外科学 | 5886篇 |
综合类 | 2662篇 |
一般理论 | 3篇 |
预防医学 | 548篇 |
眼科学 | 293篇 |
药学 | 903篇 |
35篇 | |
中国医学 | 765篇 |
肿瘤学 | 962篇 |
出版年
2024年 | 43篇 |
2023年 | 230篇 |
2022年 | 505篇 |
2021年 | 681篇 |
2020年 | 754篇 |
2019年 | 532篇 |
2018年 | 460篇 |
2017年 | 580篇 |
2016年 | 676篇 |
2015年 | 614篇 |
2014年 | 1268篇 |
2013年 | 1242篇 |
2012年 | 1121篇 |
2011年 | 1262篇 |
2010年 | 1002篇 |
2009年 | 1015篇 |
2008年 | 908篇 |
2007年 | 1001篇 |
2006年 | 898篇 |
2005年 | 772篇 |
2004年 | 691篇 |
2003年 | 481篇 |
2002年 | 336篇 |
2001年 | 291篇 |
2000年 | 233篇 |
1999年 | 186篇 |
1998年 | 185篇 |
1997年 | 154篇 |
1996年 | 103篇 |
1995年 | 103篇 |
1994年 | 84篇 |
1993年 | 77篇 |
1992年 | 68篇 |
1991年 | 71篇 |
1990年 | 56篇 |
1989年 | 63篇 |
1988年 | 46篇 |
1987年 | 44篇 |
1986年 | 46篇 |
1985年 | 35篇 |
1984年 | 34篇 |
1983年 | 23篇 |
1982年 | 25篇 |
1981年 | 40篇 |
1980年 | 30篇 |
1979年 | 14篇 |
1978年 | 11篇 |
1977年 | 12篇 |
1975年 | 8篇 |
1972年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
《Seminars in Arthroplasty》2022,32(4):681-687
BackgroundThe objective of this study was to compare complication rates between patients undergoing reverse shoulder arthroplasty (RSA) after a prior open reduction and internal fixation (ORIF) for proximal humerus fracture (PHF) to those undergoing RSA as a primary treatment for PHFs, glenohumeral osteoarthritis, or rotator cuff tear arthropathy (CTA).MethodsPatients who underwent RSA between 2015 and 2020 were identified in the Mariner database. Patients were separated into 3 mutually exclusive groups: (1) RSA for osteoarthritis, rotator cuff tear, or CTA (Control-RSA); (2) RSA as a primary treatment for PHF (PHF-RSA); and (3) RSA for patients with prior ORIF of PHFs (ORIF-RSA). Ninety-day medical and 2-year postoperative surgical complications were identified. In addition, patients in the PHF-RSA group were subdivided into those undergoing RSA for PHF within 3 months of the fracture (acute) vs. those treated greater than 3 months from diagnosis (delayed). Multivariate regression was performed to control for differences in comorbidities and demographics.ResultsA total of 30,824 patients underwent primary RSA for arthritis or CTA, 5389 patients underwent RSA as a primary treatment for a PHF, and 361 patients underwent RSA after ORIF of a PHF. ORIF before RSA was associated with an increased risk of overall revision (odds ratio [OR] 2.45, P = .002), infection (OR 2.40, P < .001), instability (OR 2.43, P < .001), fracture (OR 3.24, P = .001), minor medical complications (OR 1.59, P = .008), and readmission (OR 2.55, P = .001) compared with the Control-RSA cohort. RSA as a primary treatment for PHF was associated with an increased risk of 2-year revision (OR 1.60, P < .001), infection (OR 1.51, P < .001), instability (OR 2.84, P < .001), and fracture (OR 2.54, P < .001) in addition to major medical complications (OR 2.02, P < .001), minor medical complications (OR 1.92, P < .001), 90-day emergency department visits (OR 1.26, P < .001) and 90-day readmission (OR 2.03, P < .001) compared with the Control-RSA cohort. The ORIF-RSA group had an increased risk of periprosthetic infection (OR 1.94, P = .002) when compared with the PHF-RSA cohort. There were no differences in medical or surgical complications in the RSA-PHF cohort between patients treated in an acute or delayed fashion.ConclusionRSA following ORIF of a PHF is associated with increased complications compared with patients undergoing RSA for nonfracture indications. Prior ORIF of a PHF is also an independent risk factor for postoperative infection after RSA compared with patients who undergo RSA as a primary operation for fracture. The timing of RSA as a primary operation for PHF does not appear to impact the rates of postoperative medical and surgical complications. 相似文献
3.
4.
5.
《中国现代医生》2020,58(4):182-184+188
目的 探讨脊柱后路内固定术后硬膜外血肿的预防与护理体会。方法 遵照回顾性分析法选择我院2013年2 月~2018 年2 月纳入的60 例脊柱后路内固定术患者,依照不同理疗方式进行分组。其中30 例给予常规药物治疗作为对照组,另30 例除了常规治疗之外实施综合护理作为研究组,记录两组硬膜外血肿、腰椎术后血肿及颈椎术后血肿发生率,分别在干预前后进行生活质量评分(QOL)调查,出院时发放满意度调查问卷表,对比两组干预结果。结果 研究组血肿发生率为6.67%,明显低于对照组的20.00%(P<0.05)。干预前两组的食欲、精神、睡眠、疼痛及日常生活评分相比差异无统计学意义(P>0.05),干预后研究组的各项评分均高于对照组(P<0.05)。研究组对干预效果的满意度为90.00%,明显高于对照组的76.67%(P<0.05)。结论 护理干预运用于脊柱后路内固定中效果显著,能够有效减少硬膜外血肿的发生率,提升生活质量,促进病情稳定,患者满意度较高,可维持良好医患关系。 相似文献
6.
Biodegradable Polydioxanone Microspheres for Transcatheter Arterial Embolization: Proof of Principle
《Journal of vascular and interventional radiology : JVIR》2020,31(12):2132-2140.e5
PurposeTo evaluate feasibility, embolization success, biodegradability, reperfusion, and biocompatibility of biodegradable microspheres (MS) made from polydioxanone (PDO) for transcatheter arterial embolization.Materials and MethodsUnilateral selective renal embolization of a segmental artery was performed in 16 New Zealand White rabbits with PDO-MS (100–150 μm and 90–315 μm). Animals were randomly assigned to different observation periods and underwent control digital subtraction angiography (DSA) and MR imaging immediately (n = 3), 1 week (n = 2), 4 weeks (n = 2), 8 weeks (n = 2), 12 weeks (n = 5), and 16 weeks (n = 2) after embolization. Kidneys were harvested for macroscopic and histologic analysis of embolization success, biodegradability, and biocompatibility.ResultsEmbolization was technically successful in 15 of 16 animals. One animal died of anesthesia-related circulatory failure. The 100–150 μm MS were injected easily through 3-F catheters; the 90–315 μm MS tended to clog with intermittent catheter obstruction. DSA and MR imaging showed successful target embolization in 13 of 15 animals. In 2 animals, the entire kidney was affected owing to catheter clogging, including a reflux of MS while flushing. Control DSA and MR imaging showed increasing vascular reperfusion with time. Macroscopic and histologic analysis revealed necrosis/infarction in areas in which embolization was achieved. MS were extensively degraded after 16 weeks, and overall inflammatory reaction was mild.ConclusionsBiodegradable PDO-MS induced effective embolization of target vessels while demonstrating good biocompatibility. MS increasingly dissolved at 16 weeks, partial reperfusion started at week 1, and complete reperfusion started at week 8, thus offering possible advantages as a temporary embolic agent. 相似文献
7.
目的::研究股骨近端空心锁定板内固定治疗股骨颈骨折的临床效果。方法:对2008年2月至2010年4月我院入院治疗的108例股骨颈骨折患者进行了研究,随机分为两组,对照组给与空心钉进行治疗,观察组采用股骨近端空心锁定板内固定治疗,比较两组治疗方案的手术时间、出血量、住院时间以及下床时间,比较两组治疗方案的手术并发症发生率,并比较两组患者三年期临床疗效。结果:观察组患者手术出血量明显少于对照组,手术时间、住院时间以及下床时间明显短于对照组,两组比较差异明显,有统计学意义( P<0.05);两组患者手术并发症均以疼痛、骨不连以及感染为主,其中观察组上述并发症的发生率为13.0%,明显低于对照组33.3%,两组比较差异有统计学意义( P<0.05);观察组患者三年临床总有效率为79.6%,对照组患者三年期临床总有效率为51.9%,两组比较差异明显,有统计学意义( P<0.05)。结论:股骨近端空心锁定板内固定治疗股骨颈骨折临床效果显著,可以明显缩短手术时间以及住院时间,降低手术并发症,并且三年临床总有效率更高,值得临床推广应用。 相似文献
8.
目的分析成人血液系统恶性肿瘤患者接受强烈化疗后中性粒细胞减少性肠炎(NE)的发生率、危险因素及预后情况。方法收集2004至2013年接受化疗的1804例血液系统恶性肿瘤患者,记录患者血常规、凝血检测和血液生化检测结果,并记录患者年龄、性别、原发病、既往化疗次数、既往化疗方案中是否使用阿糖胞苷、临床症状、肠壁厚度、中性粒细胞最低计数、中性粒细胞缺乏持续时间、NE的治疗方法和预后等,探讨NE起病诱因、临床特征、腹部B超特点、症状的预后意义及化疗药物对发病的影响等。结果1804例患者中226例(12.5%)化疗后合并NE,化疗后10~19d起病,中位起病时间为化疗后第14天。发生NE后26例患者死亡,病死率11.5%。化疗药物包括阿糖胞苷、临床症状≥4项、中性粒细胞缺乏持续超过7d以及B超下肠壁厚度≥10mm的患者病死率相对较高。结论NE是接受强烈化疗的血液系统肿瘤患者的严重的并发症,发生NE后患者病死率较高。 相似文献
9.
目的探讨不同手术方法治疗复杂胫骨平台骨折临床疗效。方法选择2016年1月—2018年12月84例复杂胫骨平台骨折患者,随机分组。单侧锁定钢板内固定组选择单侧锁定钢板内固定手术,双侧切口双侧解剖钢板内固定组选择双侧切口双侧解剖钢板内固定。分析手术操作时间、手术失血、平均住院天数以及复杂胫骨平台骨折愈合时间;治疗前后患者视觉模拟评分和Rasmussen膝关节功能评分;膝关节僵硬发生率。结果双侧切口双侧解剖钢板内固定组视觉模拟评分和Rasmussen膝关节功能评分、手术操作时间、手术失血、平均住院天数以及复杂胫骨平台骨折愈合时间、膝关节僵硬发生率和单侧锁定钢板内固定组比较有优势,P<0.05。结论复杂胫骨平台骨折患者实施双侧切口双侧解剖钢板内固定可获得较好效果。 相似文献
10.
Gynecologic Malignancy-Associated Venous Thromboembolism and Predictive Tool at Thammasat University Hospital
下载免费PDF全文
![点击此处可从《Asian Pacific journal of cancer prevention》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Karit JayasakoonAwassada PunyashthiraBanthisa SomboonJunya PattaraarchachaiKomsun Suwannarurk 《Asian Pacific journal of cancer prevention》2022,23(6):2113-2118
Objectives: Aims were to investigate the prevalence and risk factors of venous thromboembolism (VTE) in gynecologic malignancy cases. Value of screening tool (Caprini) for prediction of VTE was also assessed. Study design: A retrospective study of gynecologic malignancy subjects who underwent major gynecological operation via exploratory laparotomy at Thammasat University Hospital, Pathum Thani, Thailand from January 2015 to December 2020. Participants were categorized into VTE and non-VTE groups. Caprini score, associated laboratory and clinical factors of both groups were evaluated. Results: A total of 392 subjects were recruited into the study. Prevalence of VTE was 7.4 (29/392) percent. VTE was diagnosed in subjects with endometrial, ovarian and cervical cancer at percentage of 7.8 (15/192), 7.9 (11/138) and 5.7 (3/53), respectively. Demographic characters of both groups were comparable. VTE group had significant more Caprini score, platelets count and platelet lymphocyte ratio (PLR) than non-VTE group. Modified Caprini score (2 multiply Caprini score plus 1 multiply PLR) was generated for better VTE prediction. Sensitivity and specificity of Caprini (≥5.5) and modified Caprini scores (≥22.8) were 72.4 vs 39.4, and 79.3 vs 52.1 percent, respectively. Conclusion: Prevalence of VTE among gynecologic malignancy cases was 7.4 percent. The modified Caprini score was an alternative VTE predictive tool. Cut-off point of modified Caprini score at equal or more than 22.8 was proposed. 相似文献